The Cost-Effectiveness of Screening in the Community to Reduce Osteoporotic Fractures in Older Women in the UK: Economic Evaluation of the SCOOP Study

Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial

(2018) Lee Shepstone et al.   LANCET

A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials

(2014) Rita Faria et al.   PHARMACOECONOMICS

A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis

(2014) Mickaël Hiligsmann et al.   PHARMACOECONOMICS

Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm

(2013) K. Kim et al.   OSTEOPOROSIS INTERNATIONAL

A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures

(2013) L. Si et al.   OSTEOPOROSIS INTERNATIONAL

Osteoporosis in the European Union: medical management, epidemiology and economic burden

(2013) E. Hernlund et al.   Archives of Osteoporosis

A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of screening older women for the prevention of fractures: rationale, design and methods for the SCOOP study

(2012) L. Shepstone et al.   OSTEOPOROSIS INTERNATIONAL

Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective

(2010) F. Borgström et al.   OSTEOPOROSIS INTERNATIONAL

Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines

(2009) Andrea Marshall et al.   BMC Medical Research Methodology

The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis

(2009) F. Borgström et al.   OSTEOPOROSIS INTERNATIONAL

The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®

(2009) F. Borgström et al.   OSTEOPOROSIS INTERNATIONAL

FRAX™ and the assessment of fracture probability in men and women from the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

The cost-effectiveness of alendronate in the management of osteoporosis

(2007) John A. Kanis et al.   BONE